These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 25034897

  • 1. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.
    Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G.
    Brain; 2014 Oct; 137(Pt 10):2731-42. PubMed ID: 25034897
    [Abstract] [Full Text] [Related]

  • 2. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, PKDS009 Study Group.
    CNS Drugs; 2004 Oct; 18(11):733-46. PubMed ID: 15330687
    [Abstract] [Full Text] [Related]

  • 3. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
    Ahlskog JE, Muenter MD.
    Mov Disord; 2001 May; 16(3):448-58. PubMed ID: 11391738
    [Abstract] [Full Text] [Related]

  • 4. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A, Forsaa EB, Pedersen KF, Tysnes OB, Larsen JP, Alves G.
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [Abstract] [Full Text] [Related]

  • 5. Motor complications in an incident Parkinson's disease cohort.
    Scott NW, Macleod AD, Counsell CE.
    Eur J Neurol; 2016 Feb; 23(2):304-12. PubMed ID: 26074125
    [Abstract] [Full Text] [Related]

  • 6. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R, Zhang BR, Pohle S, Klebe S, Lorenz D, Herzog J, Wilms H, Deuschl G, Krack P.
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [Abstract] [Full Text] [Related]

  • 7. The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.
    Kostić VS, Marinković J, Svetel M, Stefanova E, Przedborski S.
    Eur J Neurol; 2002 Jan; 9(1):9-14. PubMed ID: 11784369
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with motor complications in Parkinson's disease.
    Kadastik-Eerme L, Taba N, Asser T, Taba P.
    Brain Behav; 2017 Oct; 7(10):e00837. PubMed ID: 29075578
    [Abstract] [Full Text] [Related]

  • 9. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
    Cilia R, Cereda E, Akpalu A, Sarfo FS, Cham M, Laryea R, Obese V, Oppon K, Del Sorbo F, Bonvegna S, Zecchinelli AL, Pezzoli G.
    Brain; 2020 Aug 01; 143(8):2490-2501. PubMed ID: 32844196
    [Abstract] [Full Text] [Related]

  • 10. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel.
    Marano M, Naranian T, di Biase L, Di Santo A, Poon YY, Arca R, Cossu G, Marano P, Di Lazzaro V, Fasano A.
    Parkinsonism Relat Disord; 2019 Dec 01; 69():140-146. PubMed ID: 31759188
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C, van Hilten JJ.
    Cochrane Database Syst Rev; 2000 Dec 01; (3):CD002258. PubMed ID: 10908538
    [Abstract] [Full Text] [Related]

  • 13. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
    Schrag A, Quinn N.
    Brain; 2000 Nov 01; 123 ( Pt 11)():2297-305. PubMed ID: 11050029
    [Abstract] [Full Text] [Related]

  • 14. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.
    Jankovic J.
    Mov Disord; 2005 Nov 01; 20 Suppl 11():S11-6. PubMed ID: 15822109
    [Abstract] [Full Text] [Related]

  • 15. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A.
    Parkinsonism Relat Disord; 2005 May 01; 11(3):151-5. PubMed ID: 15823479
    [Abstract] [Full Text] [Related]

  • 16. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG, Stebbins GT, Blasucci LM.
    Mov Disord; 2000 May 01; 15(3):479-84. PubMed ID: 10830412
    [Abstract] [Full Text] [Related]

  • 17. Motor complications of chronic levodopa therapy in Parkinson's disease.
    Miyawaki E, Lyons K, Pahwa R, Tröster AI, Hubble J, Smith D, Busenbark K, McGuire D, Michalek D, Koller WC.
    Clin Neuropharmacol; 1997 Dec 01; 20(6):523-30. PubMed ID: 9403226
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA, McDermott MP, Messing S.
    Arch Neurol; 2006 Dec 01; 63(12):1756-60. PubMed ID: 17172616
    [Abstract] [Full Text] [Related]

  • 20. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
    Picazio S, Ponzo V, Caltagirone C, Brusa L, Koch G.
    J Neurol; 2018 Sep 01; 265(9):2088-2096. PubMed ID: 29980853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.